SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: James B. Barnes who wrote (272)12/10/1997 7:06:00 PM
From: John McCarthy  Read Replies (1) | Respond to of 569
 
James -

Kansas City area!!!

That's T E R R I F I C!

And the fact that it was a rheumatologist giving
the shot is another good point.

Wonder if he knows the RIGHT WAY <g> to give the shot.
(re:The Canadian study)

Thank you very much for your post.

Regards,

John



To: James B. Barnes who wrote (272)12/10/1997 10:34:00 PM
From: chirodoc  Read Replies (1) | Respond to of 569
 
<<<<<I live in the K.C. area. On the noon news (Channel 5) they just did a story on Synvisc

..i predict that in 5 years these HA injections will be as commmonplace as nsaid's in treating knees--less side effects and local rather than systemic. between the 3 main companies, competition and sales will drop the price and improve quality. i think both biox and anik can do well.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News